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Background: Associated anomalies have been reported in around 20% of Hirschsprung patients but many Authors
suggested a measure of underestimation. We therefore implemented a prospective observational study on 106
consecutive HSCR patients aimed at defining the percentage of associated anomalies and implementing a personalized
and up-to-date diagnostic algorithm.
Methods: After Institutional Ethical Committee approval, 106 consecutive Hirschsprung patients admitted to our
Institution between January 2010 and December 2012 were included. All families were asked to sign a specific
Informed Consent form and in case of acceptance each patient underwent an advanced diagnostic algorithm,
including renal ultrasound scan (US), cardiologic assessment with cardiac US, cerebral US, audiometry, ENT and
ophthalmologic assessments plus further specialist evaluations based on specific clinical features.
Results: Male to female ratio of our series of patients was 3,4:1. Aganglionosis was confined to the rectosigmoid colon
(classic forms) in 74,5% of cases. We detected 112 associated anomalies in 61 (57,5%) patients. The percentage did not
significantly differ according to gender or length of aganglionosis. Overall, 43,4% of patients complained
ophthalmologic issues (mostly refraction anomalies), 9,4% visual impairment, 20,7% congenital anomalies of the kidney
and urinary tract, 4,7% congenital heart disease, 4,7% hearing impairment or deafness, 2,3% central nervous system
anomalies, 8,5% chromosomal abnormalities or syndromes and 12,3% other associated anomalies.
Conclusions: Our study confirmed the underestimation of certain associated anomalies in Hirschsprung patients, such
as hearing impairment and congenital anomalies of the kidney and urinary tract. Subsequently, based on our results we
strongly suggest performing renal US and audiometry in all patients. Conversely, ophthalmologic assessment and
cerebral and heart US can be performed according to guidelines applied to the general population or in case of
patients with suspected clinical features or chromosomal abnormalities. This updated diagnostic algorithm aims at
improving overall outcome thanks to better prognostic expectations, prevention strategies and early rehabilitation
modalities. The investigation of genetic background of patients with associated anomalies might be the next step to
explore this intriguing multifactorial congenital disease.
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Hirschsprung’s disease (HSCR) is a congenital multifac-
torial developmental disorder of the enteric nervous
system characterized by the absence of ganglion cells in
the hindgut with variable distal bowel involvement. This
is a rare disease, which occurs with an incidence of 1
into 5000 live births as a consequence of premature
arrest of cranio-caudal migration of neural crest derived
neuroblasts (NCN) in the hindgut, and is therefore
regarded as a neurocristopathy [1-3]. The neural crest is
one of the earliest organs to form within the developing
embryo, during formation of the neural tube. Cells of
the neural crest are pluripotential and follow migratory
pathways depending on their axial level of origin. NCN
differentiate into crucial cell types ancestors and parti-
cipate in the development of various organs such as
adrenal medulla, melanocytes, craniofacial cartilage and
bone, smooth muscle, neuroendocrine cells and sympa-
thetic and parasympathetic nervous systems, including
the enteric nervous system [3,4]. Alterations in any of
the genes involved in the enteric nervous system devel-
opment may interfere with the colonization process of
NCN and represents a primary aetiology for HSCR [5,6].
The major gene responsible for HSCR is RET, whose
mutations are detected in up to 50% of familial and in
7-35% of sporadic cases [7]. RET is crucial for the em-
bryologic development of the enteric nervous system but
also of other organs, including kidneys and urinary tract
[8]. So far, a number of other minor HSCR susceptibility
genes have been identified in less than 5% of patients
[7]. The involvement of heterogeneous genetic pathways
and pluripotential cell lineage explains why HSCR disease
can be associated to malformations basically involving all
organs and system.
Associated anomalies have been detected in between
20% and 30% of HSCR patients according to literature
[5,9,10]. In 2006, Moore SW performed a systematic
review of 18 series with 4328 patients reported in the
last forty years and suggested an average percentage of
associated anomalies of 21.1%, ranging between 5% and
35% [10]. Similarly, Amiel J and co-workers reported a
percentage of associated anomalies of around 30% [9].
Nonetheless, both Authors suggested a measure of
underestimation [9,10]. In accordance to these consi-
derations, we recently demonstrated that Congenital
Anomalies of the Kidney and Urinary Tract (CAKUT)
occur 4-folds more frequently than previously reported
[8]. As a consequence, it comes clear that the exact
clinical phenotype of HSCR patients is yet unknown and
deserves definition to provide our patients with reliable
prognostic expectations. A better knowledge of all associ-
ated anomalies in HSCR will also reveal undisclosed
genetic implications that will improve the comprehension
of HSCR pathophysiology. We therefore implemented aprospective observational cross-sectional study on 106
consecutive HSCR patients aimed at defining the percent-
age of associated anomalies and at subsequently imple-
menting an up-to-date diagnostic algorithm.
Methods
All consecutive HSCR patients who were admitted to
Giannina Gaslini Research Institute between January
2010 and December 2012 were eligible for this prospect-
ive observational cross-sectional study. Inclusion criter-
ion was the presence of a reliable diagnosis of HSCR
achieved with adequate pathological assessment [11].
Exclusion criteria were uncertain diagnosis and/or re-
fusal to participate.
This study received Institution Review Board approval
on the 15th of October 2009. After enrolment, patients
and parents were interviewed to collect demographic
data, personal and family history and any information
regarding known associated anomalies. All families were
asked to sign a specific Informed Consent form and in
case of acceptance each patient underwent an advanced
non-invasive diagnostic algorithm, including ultrasound
scan (US) of the kidney and urinary tract, cardiologic assess-
ment with cardiac US, audiometry and ENT assessment,
ophthalmologic assessment, cerebral US (< 1 year-old),
and further specialist investigations based on clinical
features. All these non-invasive investigations were per-
formed according to widely accepted guidelines. The
following data were collected according to the Personal
Data Protection Act:
 Demographics
 Personal and family history.
 Length of aganglionosis [8].○ S-HSCR (aganglionosis extending up to the left
descending colon).
○ L-HSCR (aganglionosis extending beyond the
splenic flexure, up to the ascending colon and/
or caecum).
○ TCSA (aganglionosis involving the whole colon).
○ TIA (less than 20 cm of normoganglionic
bowel).
 Associated anomalies detected during the phenotype
screening.
 Other associated anomalies or syndromes not
included in the phenotype screening.
Details of phenotype screening
Cakut screening
All patients underwent renal US + urinalysis and colture.
In case of positive findings we applied widely accepted
diagnostic guidelines to properly investigate the patients
[8]. To perform renal US we used Philips iU 22 US scan-
ner (Philips, DA Best, The Netherlands) equipped with
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ducers, similarly to the study already published by our
study group in 2009 [8]. We also used the same criteria to
define all possible CAKUT variants: renal agenesis, renal
dysplasia-hypoplasia, hydronephrosis, vesicoureteric re-
flux, duplex collecting system, and horseshoe kidney [8].Cardiovacular screening
The cardiovascular screening included personal medical
history, physical examination, non invasive blood pres-
sure measurement, a twelve lead electrocardiogram and
echocardiogram. Detailed US was performed with a
pulsed, continuous, and color-Doppler provided US
system (Philips iE33), using a 5 or 8 MHz transducer.
Echo-scan was done by a transthoracic approach with
the patient in the supine and left decubitus position.
Morphological variables were measured offline by two
observers (G.T. and M.D.) who used the so called Z
score for normalization of the cardiac structures dimen-
sions to the body size [12-14].
Cardiac anatomy was routinely assessed by a segmental
approach that included the abdominal view, the subcostal
short and long axis view, the apical four-chambers view,
the parasternal short axis view at the level both of the pap-
illary muscles and of the mitral valve, the parasternal long
axis view and the suprasternal view. Two-dimensional
echocardiographic measurements included the end-sys-
tolic diameter of the aortic annulus of the Valsalva sinuses
and of the ascending aorta. These dimensions were mea-
sured from the parasternal long-axis view with the “inner
edge convention”, which uses the innermost bright edge
reflection as a contour. End-diastolic posterior wall thick-
ness, left ventricular internal dimension and interventricu-
lar septal thickness were measured through the M-mode
technique, which was performed also for calculating the
shortening fraction. Diastolic ventricular function as well
as valves function was assessed by both pulsed and con-
tinuous Doppler technique [15-18].Auditory and ent screening
We assessed the possible presence of audiologic risk
factors as those indicated by the Joint Committee of Infant
Hearing, including in-utero infections, craniofacial anom-
alies, physical findings suggesting syndromes known to in-
clude a sensorineural or permanent conductive hearing
loss, neonatal intensive care (NICU) admission longer
than 5 consecutive days, exposure to ototoxic medications,
family history and prematurity [19]. The tests used for
auditory screening depended on patients’ age and degree
of cooperation. Hearing impairment (HI) was defined in
case of hearing threshold higher than 20 dB. Deafness or
unilateral anacusia were defined in case of complete ab-
sence of response to auditory stimuli [20]. Screening wasconducted in a quiet room without visual and auditory
distractions according to widely accepted standards [21].
 From birth to 6 months of age - We used the
Automated Auditory Brain System (AABR). This
methodology measures cochlear response in the 1 to
4-kHz range with a broadband click stimulus in each
ear. The automated screener provides a pass-fail report;
no test interpretation by an audiologist is required. A
“fail” report on an AABR implies a new non-automatic
ABR test associated to ENTclinical assessment.
 From 6 months to 3 years of age - We used the
Visual Reinforcement Audiometry (VRA), a
behavioural test measuring responses of the child to
speech and frequency-specific stimuli presented
through speakers or insert earphones.
 From 3 years to 6 years of age - We used the
Conditioned Play Audiometry (CPA) through
earphones; in this test the child is conditioned to
respond when stimulus tone is heard, such as to put
a peg in a pegboard or drop a block in a box.
 From 6 years of age onwards - We used the
Conventional Audiometry (CA) in which the patient
is instructed to raise a hand in case of stimulus is
heard. Deafness or hearing impairment were defined
and graded according to widely accepted international
standards.
Ophtalmologic screening
We recorded detailed information regarding family history
and any risk factors for visual impairment, including
length of stay in NICU and gestational age and weight at
birth. Methodology differed according to the age. Visual
impairment (VI) was defined as uncorrected visual acuity
(VA) < 20/50 and was assessed only in patients older than
36 months of age. In younger patients we addressed
strabismus or other VA indirect measures.
 Before 3 years of age, we performed only an
objective evaluation due to the lack of child
compliance. After a good visual inspection to
exclude eye and eyelid malformations, anatomic
abnormality, evident strabismus, anomalies of eye
motility and head posture, we assessed:
○ Anterior segment and pupillary evaluations. The
anterior segment was evaluated using a
handheld or stand-mounted slit lamp. Pupillary
responses were tested with a hand light.
○ Cycloplegic autorefraction and keratometry,
with Plus Optix autorefractor (Plusoptix Inc.,
Atlanta, GA, USA) or Retinomax autorefractor,
(Nikon, Melville, NY, USA). Refractory defects
were defined and graded according to widely
accepted international standards [22].
Table 1 Overall details of 106 HSCR who completed the
screening during the study period
Overall, n
(screened)
% (95% CI)
Patients, n 106 (106)
Median age 2,4
Male to female ratio 3,4:1
VI or ophthalmological
issues
46 (106) 43,4% (95% CI, 34,4-52,9%)
CAKUT 22 (106) 20,7% (95% CI, 14,1-29,4%)
CHD 5 (106) 4,7% (95% CI, 2,0-10,6%)
HI or deafness 5 (106) 4,7% (95% CI, 2,0-10,6%)
CNS abnormalities 1 (43) 2,3% (95% CI, 0,4-12,1%)
Other associated anomalies 13 (106) 12,3% (95% CI, 7,3-19,9%)
Syndromes 9 (106) 9,4% (95%CI, 5,2-16,5%)
Down Syndrome 7 (106) 6,5% (95% CI, 3,2-13%)
Legend: Syndrome, Patients with known genetic abnormalities (i.e. Down
Syndrome, Cat Eye, CCHS, etc.); VI = Visual Impairment; CAKUT, Congenital
Anomalies of the Kidney and Urinary Tract; CHD, Congenital Heart Defect; HI,
Hearing Impairment; CNS, Central Nervous System.
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 After 3 years of age, throughout adolescence and
adulthood we also performed visual acuity
assessment, orthoptist screening with distance acuity
test, cover test, extrinsic ocular movements, prism
test, and Lang-stereotest. Moreover, we also looked
for the presence of amblyopia. In this age group we
resorted to subjective components thanks to reason-
ably good patients’ compliance.
Patients were divided into three different age groups:
younger than 3 (infants), between 3 and 6 (pre-school
children), and older than 6 years of age (school children)
to compare our results to literature data [22-24].
Brain screening and definition
Studies were performed with convex and linear-array
7,5 MHz transducers via the anterior fontanel in coronal
and sagittal planes. Further screening images were obtained
via other supplemental fontanels (posterior and mastoid).
The investigation was performed in all patients younger
than 12 months and/or with adequate echoic windows. We
assessed subarachnoid spaces, lobes, ventricles and midline
structures to rule out major congenital malformations [25].
Other associated anomalies and syndromes
Further investigations were performed basing on clinical
features detected during the first detailed physical exam-
ination aimed at ruling out major gross abnormalities,
including skull and facial malformations, cleft lip or
palate, gross skeletal malformations, skin pigmentation
disorders, external genitalia abnormalities, neurodeve-
lopmental delay, etc. All information regarding other
associated anomalies or syndromes reported by parents
or patients were recorded. In case of need, patients were
investigated in details according to widely accepted
standards of care. In particular, chromosome analysis,
array-CGH or direct sequencing of targeted genes was
performed basing on genetist’s suggestion after appropri-
ate dysmorphology assessment.
Statistical analysis
Descriptive statistics were reported as percentages with
95% confidence interval (CI), when indicated, in case of
categorical variables. Median and range was used for age,
given the wide variability in our series. Differences in the
frequencies of each categorical variable were evaluated by
the Chi-square test. Comparison of continuous data was
performed using the 2-tailed unpaired t test. In case of
scant data or non-normal distribution, non parametric
tests (Man-Whitney) were used. A p value lower than 0.05
was considered as statistically significant. Analyses were
performed using Stata for Windows statistical package
(release 9.0, Stata Corporation, College Station, TX).Results
Demographics
Overall, 144 consecutive HSCR patients were admitted
to the Department of Surgery of Giannina Gaslini Insti-
tute during the study period. One-hundred-and-six
(106) patients met the inclusion criteria, were enrolled
and underwent the entire phenotype screening during
the study period. Median age was 2,4 year (range
3 months to 25 years). Male to female ratio was 3,4:1.
Nineteen patients (17,9%) had ultralong HSCR (either
TCSA or TIA), 8 (7,6%) had L- HSCR, and 79 (74,5%) had
S- HSCR. A total of 112 associated anomalies were
detected in 57,5% (95% CI, 48,0-66,5%) of the patients
(61 out of 106) with a proportion that did not significantly
differ either according to length of aganglionosis or gender
(p = 0,8209 and 1,0000, respectively). Twenty-eight pa-
tients (26,4%) were already aware of their association
when they were enrolled in the study (see Table 1 for
details).
Ophtalmologic abnormalities or visual impairment
None of the patients was diagnosed with blindness. No
major ocular abnormalities were detected in our series
of patients. No family history of severe visual impair-
ment (VI) or blindness was recorded. Refractive error
or ophthalmologic issues were detected in 43,4% (95%
CI, 34,4-52,9%) of the patients (Table 2 for details).
Male to female ratio was 3,6:1. Five patients had
chromosomal abnormalities and 1 had Congenital Cen-
tral Hypoventilation Syndrome (CCHS) known to be
at higher risk for VI. We observed the following phe-
notypes: hyperopia (29,2% of the overall series),
Table 2 Ophthalmologic abnormalities in 46 patients
Pt Sex HSCR type Age (m) Ophthalmologic abnormality Side VI Other anomalies
1 F TCSA 146 Mild myopia R N
2 M TCSA 12 Hyperopic astigmatism B N
3 M TCSA 32 Moderate myopia B N FMTC; CAKUT
4 M TCSA 107 Hyperopic astigmatism B N GH DEFICIENCY
5 F TCSA 16 Hyperopic astigmatism B N GUT ATRESIA
6 F L-HSCR 11 Hyperopic astigmatism B N
7 F L-HSCR 52 Severe hyperopic astigmatism B N
8 M L-HSCR 30 Mixed astigmatism + opaque iris B N ONDINE; CAKUT; CRYPTO; HI
9 M L-HSCR 62 Hyperopic anisometropia + amblyopia + ptosis L Y DOWN
10 F S-HSCR 5 Hyperopia B N
11 M S-HSCR 129 Hyperopic anisometropia + severe amblyopia R Y CAKUT
12 F S-HSCR 41 Hyperopia B N
13 M S-HSCR 3 Hyperopic anisometropia L N
14 M S-HSCR 37 Hyperopic astigmatism R N
15 M S-HSCR 70 Hyperopic astigmatism B N
16 F S-HSCR 26 Myopic astigmatic anisometropia L N
17 F S-HSCR 30 Hyperopic astigmatism B N
18 M S-HSCR 17 Hyperopic astigmatism B N
19 M S-HSCR 4 Hyperopia L N
20 M S-HSCR 133 Mixed astigmatism B N FMTC
21 M S-HSCR 5 Hyperopic astigmatism B N
22 M S-HSCR 69 Hyperopic astigmatism L N
23 M S-HSCR 76 Hyperopia B N CAKUT
24 M S-HSCR 26 Hyperopic astigmatism B N CAKUT
25 M S-HSCR 11 Hyperopic astigmatism B N DOWN; CHD
26 M S-HSCR 44 Hyperopic astigmatism + amblyopia L Y
27 M S-HSCR 76 Hyperopic astigmatism B N CAKUT; HI
28 F S-HSCR 248 Myopia B N CAKUT; HI
29 M S-HSCR 16 Diverging strabismus B Y CAT EYE; CHD; CAKUT; VI;
EAR PIT
30 M S-HSCR 3 Hyperopic astigmatism B N
31 M S-HSCR 220 Mixed astigmatism B N CAKUT
32 M S-HSCR 54 Hyperopic astigmatism +mixed amblyopia L Y
33 M S-HSCR 161 Myopic astigmatism L N CRYPTO; HYPERTG
34 M S-HSCR 288 Vertical strabismus L Y OSTEOPOROSIS
35 M S-HSCR 113 Myopic astigmatism B N
36 F S-HSCR 290 Hyperopic astigmatism + strabismus B Y DOWN; CHD; CAKUT
37 M S-HSCR 77 Amblyopia L Y
38 M S-HSCR 152 Severe myopia + converging strabismus L Y DOWN; CHD
39 M S-HSCR 109 Hyperopic astigmatism B N ADHD
40 M S-HSCR 154 Myopia B N CAKUT; DYSLESSIA; CCA
41 M S-HSCR 4 Hyperopic astigmatism B N
42 M S-HSCR 101 Hyperopic astigmatism B N
43 M S-HSCR 49 Hyperopia B N CAKUT
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Table 2 Ophthalmologic abnormalities in 46 patients (Continued)
44 M S-HSCR 138 Hyperopic anisometropia B N
45 M S-HSCR 142 Strabismus B Y EARLY PUBERTY
46 M S-HSCR 44 Hyperopic astigmatism B N CAKUT
LEGEND: GH, Growth Hormone; ADHD, Attention Deficit Hyperactivity Disorder; CCA, Corpus Callosum Agenesis; B, Bilateral; L, Left; R, Right; VI, Visual
impairment; Y, Yes; N, No.
Incidence of visual impairment was 9,4%.
Table 3 Details of 22 patients with CAKUT
ID Sex HSCR type CAKUT Side Other anomalies
1 M TIA MCDK R
2 F TCSA RH B HI
3 M TCSA RA L FMTC; VI
4 M TCSA VUR B
5 M L-HSCR RH R ONDINE; CRYPTO; VI; HI
6 M S-HSCR RH R VI
7 M S-HCSR DCS L VI
8 M S-HCSR HN B VI
9 M S-HCSR HN L PALATE CLEFT
10 M S-HSCR VUR R EAR PIT
11 F S-HCSR RH + DCS B VI; HI
12 M S-HCSR RH L VI; HI
13 M S-HCSR VUR B CAT EYE; CHD; VI; EAR PIT
14 M S-HSCR RH R VI
15 F S-HSCR RH B
16 M S-HSCR RH + HN B DOWN; CHD; VI
17 M S-HSCR VUR R
18 M S-HSCR HN B VI; DISLESSIA; CCA
19 M S-HSCR HN L VI
20 M S-HSCR VUR + PUV + RH R
21 F S-HSCR RH R VI
22 M S-HSCR VUR L DOWN; ATRESIA
Legend: TIA, Total Intestinal Aganglionosis; TCSA, Total colonic aganglionosis;
L-HSCR, Aganglionosis extended between left transverse colon and the cecum;
S-HSCR, Aganglionosis extending up to the splenic flexure; MCDK, Multicystic
Dysplastic Kidney; RH, Renal hypoplasia; RA, Renal Asymmetry; HN,
Hydronephrosis; VUR, Vesicoureteric Reflux; DCS, Duplex Collecting System;
PUV, Posterior urethral valve; R, Right; B, Bilateral; L, Left; HI, Hearing
impairment; FMTC, Familiar Medullary Thyroid Carcinoma; VI, Visual
Impairment; CRYPTO, Cryptorchidism; CHD, Congenital Heart Disease; CCA,
Corpus Callosum Agenesis.
Sixteen right and 14 left rental units were involved for a slight right side
preponderance. Most of HSCR patients with CAKUT (17/22 = 77%) had further
associated malformations.
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amblyopia (4,7%), papilla abnormalities (1,9%), opaque
iris (0,9%) and severe ptosis (0,9%). Twenty-eight pa-
tients were diagnosed during the phenotype screening.
Ophthalmologic abnormalities were observed in 34% of
the patients younger than 3, in 48% of those aged be-
tween 3 and 6 and in 54% of those older than 6 years of
age. Overall percentage of VI was 9,4%.
Cakut
CAKUT were detected in 20,7% (95% CI, 14,1-29,4%)
of the patients. Male to female ratio was 4,5:1. One
patient had a clear familial history of CAKUT. We
observed a total of 26 abnormalities with a slight
right-sided preponderance (right to left ratio = 1,14:1)
(Table 3 for details). Three patients had two or more
co-existing CAKUT. Thirteen patients were diagnosed
during the phenotype screening. In 7 patients CAKUT
were symptomatic with urinary tract infections requiring
medications (antibiotics either for treatment or prophy-
laxis) and long-term follow-up. Three patients required
surgery.
Congenital heart diseases (CHD)
Major CHD were detected or confirmed during pheno-
type screening in 4,7% (95% CI, 2–10,6%) of the patients
(Table 4 for details). Male to female ratio was 1,5:1. No
positive family history was reported by any of the pa-
tients. CHD were represented by septal defects (either
atrial or ventricular) in all patients but one. Four pa-
tients, all carrying chromosomal abnormalities, had se-
vere CHD requiring surgical correction. In addition to
the above-mentioned abnormalities, we detected ostium
secundum type ASD in 4 patients and dilatation of the
aortic sinus in 3. Those patients are being followed up in
the long term. See Table 4 for details.
Hearing impairment (HI), deafness or ent anomalies
HI or deafness were reported in 4,7% (95% CI, 2–10,6%)
of the patients with slight female preponderance. Two
further patients (1,9%) had congenital preauricular fis-
tulas (Ear pit) (Table 5 for details). No positive family
history was reported by any of the patients. We observed
the following HI: 3 sensorineural hypoacusia, 1 mixed
sensorineural/conductive hypoacusia and 1 unilateral
deaf. No bilateral involvement was reported. One patienthad CCHS known to be potentially associated to HI.
Four patients were diagnosed during the phenotype
screening. In addition to the above-mentioned anomalies
we could detect bilateral deep at frequencies higher than
8000 Htz in 3 patients and conductive HI in 12, mostly
related to upper airways infections or mucous retention.
Table 4 Details of HSCR patients with CHD
Pt ID Sex Age (m) HSCR type Disease Management Other anomalies
1 F 12 TCSA AC Surgical intervention TURNER
2 F 291 S-HSCR ASD + VSD +MI Surgical intervention DOWN; CAKUT; VI
3 M 152 S-HSCR ASD + VSD Surgical intervention DOWN; VI
4 M 15 S-HSCR ASD + VSD Surgical intervention CAT EYE; CAKUT; VI; EAR PIT
5 M 3 S-HSCR ASD + small VSD F-UP DOWN
M 26 S-HSCR AS DIL. F-UP CAKUT; VI
M 52 L-HSCR AS DIL. F-UP CAKUT; EAR PIT
M 134 S-HSCR AS DIL. F-UP
M 95 TCSA ASD (OS) F-Up
M 161 S-HSCR ASD (OS) F-Up VI; IPERTG; CRYPTO
M 288 S-HSCR ASD (OS) F-Up VI; OSTEOPOROSIS
M 40 S-HSCR ASD (OS) F-Up DOWN
Legend: AC = Aortic Coarctation; ASD = Atrial Septal Defect; VSD = Ventricular Septal Defect; MI = Mitral Insufficiency; F-UP = Follow up; AS DIL. = Aortic
Sinus Dilatation.
Five patients were diagnosed with major CHD (4.7%). Four patients required cardiac surgery. All patients with CHD suffered from chromosomal abnormalities
(3 Down, 1 Cat Eye, and 1 Turner Syndrome). In addition to the above-mentioned abnormalities, we detected dilatation of the aortic sinus in 3 patients and ostium
secundum type ASD in 4. All those patients are being followed up in the long term.
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Corpus callosum agenesis was detected in 2,3% (95%
CI, 0,4-12,1%) of the patients (1 out of 43 HSCR pa-
tients who underwent cerebral US). No other major
brain abnormalities were detected. We identified ven-
tricle asymmetry or subarachnoid spaces dilatation in
7 patients (16%) all with left side involvement. More-
over, we detected a mild hydromielic spinal cavity in
a patient who underwent MRI for other reasons and
congenital thalamic calcifications of unclear aetiology
in another.Table 5 Patients with hearing impairment, deafness or
ENT anomalies
Pt Sex HSCR type ORL disease Side Other
anomalies
1 F TCSA Sensorineural
hypoacusia
L CAKUT
2 M L-HSCR Sensorineural
hypoacusia
B ONDINE; CAKUT;
VI; TESTIS
3 F S-HSCR Sensorineural
hypoacusia
B
4 M S-HSCR Preauricular fistula
(Ear Pit)
L CAT EYE; CAKUT;
CHD; VI
5 M S-HSCR Anacusia R CAKUT; VI
6 M S-HSCR Preauricular fistula
(Ear Pit)
L CAKUT
7 F S-HSCR Mixed hypoacusia +
conductive hearing loss
B CAKUT; VI
Five patients (4.7%) had sensorineural hypoacusia or anacusia. Two further
patients had minor ENT anomalies (Ear Pit). Six out of seven patients with
auditory problems or ENT anomalies had other congenital abnormalities. Right
to left ratio was 0,7:1 with slight left side preponderance.Other associated anomalies
A further 18 associated anomalies have been detected in
12,3% (95% CI, 7,3-19,9%) of the patients from our series
(12,3%). Amongst the various associated anomalies de-
tected in our study outside the phenotype screening,
endocrinologic and/or metabolic issues accounted for
4,7% of the patients (5/106), gastrointestinal abnor-
malities for 2,8% (3/106) and genital abnormalities and
tumors (FMTC) for 1,9% each (2/106). One patient with
severe developmental delay and one with corpus callo-
sum agenesis underwent molecular genetic analysis of
ZFHX1B/SIP1 to rule out Mowat-Wilson syndrome. See
Table 6 for details.
Syndromes
Chromosomal abnormalities or known syndromes (Down,
Turner, Cat Eye, Congenital Central Hypoventilation
Syndromes) have been detected in 9,4% (95% CI, 5,2-
16,5%) of the patients (Table 6). The percentage of patients
suffering from Down Syndrome in our series was 6,6%
(95% CI, 3,2-13%). With regard to associated anomalies,
syndromic HSCR patients proved to have a higher propor-
tion of CHD compared to non-syndromic HSCR patients
(p = 0,0001). Other associated anomalies have been de-
tected more frequently in syndromic HSCR but the associ-
ation proved not to be statistically significant (see Table 7
for details).
Multiple associations
Thirty-one patients (29,2%) had ≥ 2 associated anomalies
or chromosomal abnormalities. Twelve (11,3%) had ≥ 3
and 3 (2,8%) had ≥ 4. The latter patients all had known
Table 6 Other anomalies detected during the study
ID Sex HSCR type Associated anomalies Screening results
Chromosomal anomalies
1 F TCSA Down Syndrome
2 F TCSA Turner Syndrome CHD
3 M L-HSCR Down Syndrome VI
4 M S-HSCR Down Syndrome CHD; VI
5 F S-HSCR Down Syndrome CHD; CAKUT; VI
6 M S-HSCR Down Syndrome CHD; VI
7 M S-HSCR Down Syndrome
8 M S-HSCR Down Syndrome CAKUT
9 M S-HSCR Cat-Eye Syndrome CHD; CAKUT; VI; HI
Metabolic issues
10 M TCSA GH deficiency VI
11 M S-HSCR Familial Hyper-TG VI
12 M S-HSCR Hypothyroidism
13 M S-HSCR Osteoporosis VI
14 M S-HSCR Precocious Puberty VI
Gastrointestinal
abnormalities
15 F TCSA Gut Atresia VI
16* M TCSA Coeliac Disease
8 M S-HSCR Pancreas anularis CHD; CAKUT
8 M S-HSCR Malrotation CHD; CAKUT
Genital Abnormalities
17 M L-HSCR Cryptorchidism CAKUT; HI; VI
11 M S-HSCR Cryptorchidism VI
Tumors
18 M TCSA FMTC CAKUT; VI
19 M S-HSCR FMTC VI
Other Anomalies
16* M TCSA Seizures
17 M L-HSCR Ondine Syndrome CAKUT; HI; VI
20 M S-HSCR Cleft Palate CAKUT
21* M S-HSCR Dyslessia CAKUT; VI; CCA
22 M S-HSCR ADHD VI
Most of these anomalies were already known and occurred in association with
other associated anomalies in a syndromic fashion.
Legend: FMTC = Familial Medullary Thyroid Carcinoma; ADHD, Attention
Deficit Hyperactivity Disorder; CCHS, Congenital Central Hypoventilation
Syndrome; CCA, Corpus Callosum Agenesis; * = Mowat-Wilson excluded.
Four patients had more than one associated anomaly detected outside the
screening (pts number 8, 11, 16 and 17). The great heterogeneity of organs
and systems is evident in our series of patients. Only 4 of these patients had
no further anomalies detected during the study.
Table 7 Details of patients divided according to
syndromic vs non-syndromic features
Syndromic,
n (%, 95%CI)
Non-syndromic,
n (%, 95% CI)
p
Patients, n 10 (9%, 5%-16%) 96 (91%, 83%-95%)
Median age 2,25 2,42 n.a.
Male to female
ratio
2,33:1 3,57:1 0,6912
S-HSCR 6 (60%, 31%-83%) 73 (76%, 67%-83%) 0,2719
Other HSCR forms 4 (40%, 17%-69%) 23 (24%, 16%-33%)
VI 6 (60%, 31%-83%) 40 (41,7) 0,7918
CAKUT 4 (40%, 17%-69%) 18 (18,7) 0,2106
CHD 5 (50%, 24%-76%) 0 (0%, 0%-5%) 0,0001
HI 1 (10%, 18%-40%) 4 (4%, 2%-10%) 0,3968
CNS anomalies 0 (0%, 0%-33%) 1 (1%, 0,2%-57%) 1,000
OTHER 3 (30%, 11%-60%) 10 (10%, 6%-18%) 0,1044
Legend: n.a., Not assessed.
Although associated anomalies were encountered more frequently in
syndromic patients, only CHD showed a statistically significant association.
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Discussion
This is the first prospective observational study aimed at
defining the spectrum of possible phenotypes in a large
cohort of HSCR patients. A reason why none previously
addressed this issue probably relies on the rarity of the
disease and on the difficulty to organize and perform
such complex multidisciplinary prospective clinical as-
sessments. In fact, literature reports regarding associated
anomalies in HSCR are merely retrospective assessments
of surgical series or systematic literature reviews [5,9,10].
The results of our study are remarkable and confirmed
a measure of underestimation already suggested by some
[5,8-10,26,27]. In particular, we demonstrated that the
percentage of associated anomalies is higher than expected
with involvement of basically all organs and systems.
Delayed diagnosis or mild symptoms can explain the
reason for such a discrepancy. In fact, refractive anomal-
ies or visual impairment (VI), mild CAKUT or unilateral
hearing impairment (HI) can be diagnosed with signi-
ficant delay in the absence of specific screening pro-
grammes [8,19,28].
With regard to phenotype considerations, our study
confirmed the high percentage of CAKUT in HSCR pa-
tients, as previously published [8]. In fact, despite some
overlap of patients included in both studies (17% of cases),
the percentage of associated CAKUT remained constantly
high as well as the preponderance of hypoplasia, vesico-
ureteric reflux and hydronephrosis amongst detected mal-
formations. Based on the results of our studies, we thus
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diagnostic investigation in all HSCR patients.
We could not detect any major ocular anomaly in our
series of HSCR patients but nearly 10% of VI and more
than 40% of refraction abnormalities. The latter are fre-
quent in HSCR patients as well as in the general popula-
tion. In 2009, the Baltimore Pediatric Eye Disease Study
indicated in 0,7% the prevalence of myopia and nearly
9% that of hyperopia, in 1030 white Americans younger
than 6 years of age [22]. Similarly, in 2011 the Sydney
Pediatric Eye Disease Study examined 2461 children
younger than 6 years of age and suggested an incidence
of 6,4% of VI mostly due to refractive errors, amblyopia,
and strabismus [23]. In 2008 Jobke and co-workers per-
formed a population-based study on 516 German chil-
dren, adolescent and young adults aged between 2 and
35 years and ended up with a prevalence of over 75% of
emmetropia, nearly 20% myopia and 5% hyperopia [24].
Due to the heterogeneity of literature data regarding the
general population, we can hardly determine the relative
risk of HSCR patients of having refraction abnormalities.
Nonetheless, based on embryologic considerations re-
garding the shared neural crest origin of enteric nervous
system and specific ocular structures and on the relatively
high percentage of patients with refractive errors and VI
observed in our study, we strongly recommend to perform
routine ophthalmologic assessments (as those performed
in the general population) in order to early detect and
prevent VI, in accordance to WHO suggestions [28,29].
The prevalence of major or moderate CHD has been
reported to be around 7,2 per 1000 live birth in the
general population [30], whereas the proportion of CHD
in HSCR patients has been reported to be around 5%,
according to literature [5,9,10]. We could basically con-
firm these data (4,7% in our series). In particular, CHD
detected during phenotype screening mostly occurred in
patients with chromosomal abnormalities and were
essentially represented by septal defects. This is in ac-
cordance with the embryologic role of NCN in the de-
velopment of both enteric nervous system and cardiac
outflow septation [31]. On the other hand, none of the
patients presented conotruncal heart defects, whose
pathogenesis is similarly related to the abnormal neural
crest cell proliferation and migration [31]. The percent-
age of minor CHD or trivial lesions without clinical sig-
nificance in our series accounted for another 6,6% of
patients, well within literature ranges [30]. Based on
these results we do suggest performing cardiac US only
in the subpopulation of known or suspected syndromic
HSCR patients.
In the general population, the incidence of HI in subjects
without audiological risk factor is around 1,5‰, whereas
that of subjects with audiological risk factors is 4,5%
[32,33]. With specific regard to HSCR patients, syndromicHI can be found in patients with Waardenburg-Shah type
4, due to mutations of SOX10 gene [5,9,10]. Of note in
1973 Skinner described 4 patients with congenital deafness
and HSCR and suggested that this association could not be
fortuitous but based on shared embryological background
as only one case had known risk factors for HI (strepto-
mycin administration) [34]. Based on these considerations
and on the results of our study (4,7% of HI), we recom-
mend that HSCR itself should be included amongst risk
factors for HI. Subsequently HSCR patients should
undergo specific audiologic screening programmes as those
suggested by the Joint Committee of Infant Hearing in
2007 [19].
Although Moore reported a relatively high proportion
of brain abnormalities in HSCR patients, we could only
confirm a case of corpus callosum agenesis in a patient
of ours who was already diagnosed with prenatal US
[10,26]. The child had no further syndromic features and
a near-normal neurologic development (mild dyslexia).
In our series of patients we could also detect some ven-
tricle asymmetry and subarachnoid spaces dilatations
that were found in less than 20% of cases, mostly on the
left hand side. Of note, asymmetry between the sizes of
the ventricles can be observed in up to 40% of healthy
infants, being the left ventricle often larger than the right
[25]. Based on these results and in accordance with lit-
erature data, we do not recommend performing routine
cerebral US in all HSCR patients but only in those with
clear syndromic features who have higher likelihood
of carrying cerebral malformations (i.e. Mowat-Wilson
Syndrome) [10,26,35].
Amongst other associated anomalies (Table 6) tumors
were exclusively represented by FMTC, well known to
be associated with specific genotypes at the RET gene
locus in HSCR patients [7]. As expected, after testing for
mutations of the RET gene (data not shown), we could
verify that the two patients of our panel who are affected
with HSCR + FMTC syndromic association are indeed
carriers of the p.C609Y and p.Y791F mutations, respect-
ively. These mutations have already been reported in asso-
ciation with this combined phenotype and also described
as “Janus mutations” [36].
The percentage of anomalies that could have been
tracked down retrospectively by notes reviews or question-
naire administration resembles that of literature reports
[5,9,10]. In fact, 26,4% of patients was already aware of their
association when they entered our screening programme.
This aspect further confirms the reliability of our results
and that a deeper clinical screening could have detected the
missed associated anomalies (“the more you look for, the
more you find”).
Besides providing a novel view on clinical associations
and variable symptoms of HSCR disease in children, the
present data prompt us to deepen into follow-up data
Pini Prato et al. Orphanet Journal of Rare Diseases 2013, 8:184 Page 10 of 12
http://www.ojrd.com/content/8/1/184from adults who were treated for HSCR, which are
lacking at the moment. Indeed, we cannot exclude that
additional organs or systems can be involved and be-
come impaired later in adult life. Indeed, typical adult-
hood associated diseases have not been described yet
and are unknown at the moment. For instance, associ-
ation with specific cancers, nervous degeneration, intes-
tinal chronic inflammation and/or other late-onset
disorders cannot be ruled out and further investigation
in an adult set of HSCR patients would be advisable.
Our Institution is known to be a referral centre for
HSCR with an intrinsic subsequent risk of inclusion
BIAS. This concern was confirmed by the higher than
expected percentage of ultralong forms of the disease in
our series (17,9%). Nonetheless, given the fact that the
percentage and type of associated anomalies did not cor-
relate to gender or length of aganglionosis, the results of
our study maintained their strength. Furthermore, the
percentage of Down Syndrome as well as the strong
male preponderance observed in our series of patients
are coherent with literature data and confirm that the
results of our study are representative of the whole
HSCR population [5,9,10].
The relatively small population of this observational
study represents another potential limitation. As a con-
sequence, the estimates we could provide have the in-
trinsic limitation of a wide variability and should be
taken with care (see Tables 1 and 7 for details). Nonethe-
less, HSCR is a rare disease and the number of patientsFigure 1 Proposed diagnostic workup for patients with a reliable diag
the present of sure or suspected chromosomal abnormalities.enrolled in such a relatively small time-span implies
strong commitment and a multidisciplinary approach
that deserve consideration.
It is evident that the implementation of a prospective
multicentre research project is warranted. In fact, a lar-
ger series of patients could increase the strength of the
results and possibly confirm the cost-effectiveness of this
proposed diagnostic algorithm for a significant change
in clinical practice for HSCR management (Figure 1).
Conclusions
Based on the results of our study, we suggest performing
US of the kidney and urinary tract as well as audiologic
investigation in all cases, whereas heart US, cardiologic
assessment, cerebral US and ophthalmologic assessment
should be performed basing on clinical features and ac-
cording to the standards of care adopted for the general
population. On the other hand, all investigations should
be considered for patients with known or suspected
syndromes or chromosomal abnormalities in order to
promptly apply specific prevention strategies, as we
already suggested (i.e. preoperative prophylactic stoma
and postoperative rectal irrigations in case of associated
CHD) [37]. Figure 1 shows a suggested diagnostic algo-
rithm. It includes early clinical genetic assessment in
order to detect symptoms and signs suggestive of syn-
dromes that would lead to further investigations.
Early diagnosis of associated anomalies provides more
reliable prognostic expectations, prompt establishmentnosis of Hirschsprung’s disease. Algorithm changes according to
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rehabilitation treatments. In accordance to our previous
publication and to present results, we hypothesize that
intestinal aganglionosis in HSCR patients represents
the intestinal phenotype of a more complex syndrome
driven by the interaction of neural crest maldevelopment
and predisposing genetic background [5,7-10,29,31]. The
investigation of genetic background of individuals present-
ing with associated anomalies might be the next step to
explore this intriguing multifactorial congenital disease.
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